DS
The SYNTAX® Platform provides enzymatic, on‑demand synthesis of high‑quality single‑stranded DNA oligonucleotides. Laboratories can generate custom ssDNA overnight, enabling faster synthetic biology workflows for biotech, pharma, CROs and core facilities.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- This company provides the SYNTAX® Platform and associated kits for in-house, on-demand synthesis of high-quality single-stranded DNA (ssDNA) oligos. Their enzymatic DNA synthesis technology enables laboratories to produce custom oligos overnight, offering greater control and speed for synthetic biology workflows. This capability is designed to serve biotech, pharma, CROs, and core facilities requiring reliable and rapid oligonucleotide access.